台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣諾華股份有限公司 台北市中山區民生東路三段2號8樓 (01516589) - ranibizumab - 注射劑 - ranibizumab (1013002100) mg - ranibizumab - 成人：(1) 治療脈絡膜血管新生(choroidal neovascularization , cnv)所導致的視力損害。(2) 治療血管新生型(濕性)年齡相關性黃斑部退化病變(age-related macular degeneration, amd)。(3) 治療糖尿病引起黃斑部水腫(diabetic macular edema, dme)所導致的視力損害。(4) 治療視網膜靜脈阻塞(分支或中央視網膜靜脈阻塞；branch or central retinal vein occlusion； brvo 或 crvo) 續發黃斑部水腫所導致的視力損害 (5) 治療中重度非增殖性糖尿病視網膜病變(moderately severe or severe non-proliferative diabetic retinopathy, npdr)及增殖性糖尿病視網膜病變(proliferative diabetic retinopathy, pdr)。早產兒：早產兒視網膜病變(retinopathy of prematurity, rop)

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

臺灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - methionine;;phenylalanine;;threonine;;tryptophan;;arginine monoglutamate l-;;histidine hcl monohydrate;;alanine;;aspartic acid;;glutamic acid;;proline;;serine;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;potassium hydroxide;;sodium hydroxide;;glucose (monohydrate);;sodium chloride;;calcium chloride dihydrate;;leucine;;lysine hcl;;glycine (eq to aminoacetic acid)(eq to glycocoll);;magnesium acetate tetrahydrate;;valine;;isoleucine;;potassium dihydrogen phosphate - 注射劑 - sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) 1.56gm; calcium chloride dihydrate (4012000350) 0.37gm; magnesium acetate tetrahydrate (4012001450) 0.86gm; sodium chloride (4012002100) 0.17gm; glucose (monohydrate) (4020009760) 88.00gm; alanine (4020100200) 4.85gm; arginine monoglutamate l- (4020100342) 4.98gm; aspartic acid (4020100400) 1.50gm; glutamic acid (4020100700) 1.22gm; histidine hcl monohydrate (4020100915) 1.69gm; isoleucine (4020101000) 2.34gm; leucine (4020101200) 3.13gm; lysine hcl (4020101310) 2.84gm; methionine (4020101500) 1.96gm; phenylalanine (4020101700) 3.51gm; proline (4020101800) 3.40gm; serine (4020101900) 3.00gm; threonine (4020102000) 1.82gm; tryptophan (4020102100) 0.57gm; valine (4020102300) 2.60gm; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 1.65gm; potassium dihydrogen phosphate (5612001920) 0.78gm; potassium hydroxide (9600024100) gm; sodium hydroxide (9600028200) 0.50gm - combinations - 無法經口服攝食或腸道吸收營養、功能不全或有禁忌症時，對輕微到中等異化作用狀態的病人的靜脈營養提供氨基酸、葡萄糖、電解質和液體。欣保康力靜脈營養輸注液適用於成人和2 到17 歲的兒童。

台湾 - 中文 - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

台灣邁蘭有限公司 臺北市信義區信義路５段7號27樓 (25122352) - docetaxel anhydrous - 注射劑 - docetaxel anhydrous (1013000220) mg - docetaxel - 乳癌、非小細胞肺癌、前列腺癌、胃腺癌、頭頸癌。